Lantern Pharma
LTRN
LTRN
31 hedge funds and large institutions have $8.59M invested in Lantern Pharma in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0.71% less ownership
Funds ownership: 23.17% → 22.46% (-0.71%)
3% less funds holding
Funds holding: 32 → 31 (-1)
Holders
31
Holding in Top 10
1
Calls
$119K
Puts
$5K
Top Buyers
| 1 | +$87.7K | |
| 2 | +$45K | |
| 3 | +$12.5K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$9.83K |
| 5 |
Renaissance Technologies
New York
|
+$5.31K |
Top Sellers
| 1 | -$12.8M | |
| 2 | -$120K | |
| 3 | -$119K | |
| 4 |
Two Sigma Investments
New York
|
-$52.8K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$40.2K |